OptimizeRx to Participate at Lake Street Annual Best Ideas Growth Conference on September 12, 2019
August 29 2019 - 8:31AM
OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital
health messaging for the pharmaceutical industry, has been invited
to participate in the Lake Street Capital Markets 3rd Annual Best
Ideas Growth (BIG3) Conference being held on September 12, 2019 at
the Parker New York.
OptimizeRx CEO William Febbo is scheduled to participate in
one-on-one meetings. He will discuss a number of topics, including
the company’s record Q2 results, its new business intelligence and
communications services, and how the company is supporting better
health outcomes through its digital health network that now reaches
more than a million doctors and patients nationwide.
The company’s digital health network is expanding into the acute
care market after reaching more than half of the ambulatory patient
market in the U.S.
The BIG3 event brings together more than 60 dynamic small-cap
publicly traded company management teams to interact with over 100
institutional accounts from across the country in a one-on-one
meeting format.
The event is for institutional clients of Lake Street and is by
invitation only. To schedule a one-on-one meeting with OptimizeRx,
please contact your Lake Street sales representative or
conference@lakestreetcm.com. For any questions about OptimizeRx,
contact Ron Both of CMA at (949) 432-7557 or submit your request
here.
About OptimizeRx
OptimizeRx® (NASDAQ: OPRX), a digital health company, connects
pharmaceutical companies to patients and providers, offering
greater affordability, adherence and brand awareness at the
point-of-care. As the nation’s largest point-of-prescribe
promotional platform for the pharmaceutical
industry, OptimizeRx provides a direct channel for pharma
companies to communicate with healthcare providers right within
their workflow and also directly to patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half
of the ambulatory patient market with access to these benefits
through leading EHR platforms like Allscripts, Amazing Charts and
Quest, and directly via its mobile communications
platform.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended, and such as in section 21E of the Securities Act of 1934,
as amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
OptimizeRx Contact Doug
Baker, CFO Tel (248) 651-6568
x807 dbaker@optimizerx.com
Media Relations Contact Nicole
Brooks, Innsena Communications Tel (860) 800-2344 nicolebrooks@innsena.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Apr 2023 to Apr 2024